LinkedIn Profile

Access OcuSciences historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:ocusciences 3961979 May 30th, 2019 12:00AM OcuSciences 37 5.00 Open Medical Devices May 30th, 2019 04:56PM May 30th, 2019 04:56PM OcuSciences is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique called flavoprotein fluorescence (FPF). FPF is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The first device, the OcuMet Beacon, is currently being developed and validated at several top ophthalmic centers. Open medical device, flavoprotein fluorescence, ophthalmology, AMD, glaucoma Open 1777 Highland Drive Ann Arbor MI US 48108 OcuSciences
private:ocusciences 3961979 Feb 17th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 16th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 15th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 14th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 13th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 12th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 11th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 10th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences
private:ocusciences 3961979 Feb 9th, 2018 12:00AM OcuSciences 34 5.00 Open Medical Devices Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM OcuSciences, Inc., is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique. The technique, termed Retinal Metabolic Analysis (RMA), is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The device, the OcuMet Beacon, assesses the level of flavoprotein fluorescence, which is correlated to mitochondrial health, in the retinal. OcuSciences

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.